Showing 1 - 1 results of 1 for search 'Alison Forgie', query time: 0.01s
Refine Results
-
1
Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 study by Tae Min Kim, Nehal J. Lakhani, Jacob Soumerai, Manali Kamdar, Justin F. Gainor, Wells Messersmith, Philip Fanning, Shanhong Guan, Feng Jin, Alison Forgie, Hong I. Wan, Jaume Pons, Sophia S. Randolph, Won Seog Kim
Published 2025-04-01Get full text
Article